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Introduction
Currently, more than 3 million implantable cardiac pacing systems 
exist worldwide.1)2) The estimated rate of infection after permanent 
endocardial lead implantation is between 1% and 2%.3) If treatment 
of pacemaker lead infection is delayed, complications such as de-
struction of the tricuspid valve, septic pulmonary embolism, and 
consecutive abscess-forming pneumonia can occur.4) When septic 
emboli are dislodged or when lead infection is complicated by large 
vegetations, the ideal therapeutic strategy (either transvenous re-
moval or surgical ablation) is not clear but likely depends on the size 
of the vegetation. The outcomes of patients undergoing transvenous 
lead removal in endocarditis with large vegetation have not yet been 
elucidated.4) 
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We present two patients with pacemaker lead endocarditis with 
large vegetations (>2 cm). Both cases were successfully managed 
with transvenous lead removal. 
Cases
Case 1
A 63-year-old male was admitted for fever and confusion of three 
days. He had undergone pacemaker (VDD type) implantation for 
symptomatic sick sinus syndrome three months prior.
Upon admission, the patient was febrile with a temperature of 
38.3°C, confused and had dysarthric speech. Physical examination 
was remarkable for warmth, erythema, and tenderness of the skin 
overlying the pacemaker pocket, which was exposed. His white 
blood cell (WBC) count was 18.40×103/μL, and C-reactive protein 
(CRP) concentration was 148.27 mg/L. Transthoracic echocardio-
gram (TTE) revealed vegetations attached to the tricuspid valve (2.4× 
1.1 cm) (Fig. 1A, arrow), right atrium (0.8×0.8 cm) (Fig. 1A, broken ar-
row), and mitral valve (0.7×0.5 cm) (Fig. 1B, arrow). Brain magnetic 
resonance imaging results were consistent with multiple acute 
embolic infarcts (Fig. 2A). Computed tomography scan of the chest 
and abdomen showed multiple cavitary nodules in both lungs (Fig. 
2B) and small, low-attenuated lesions in segment 6 of the liver (Fig. 
2C), suggesting septic embolism.
On the same day, the patient underwent transvenous removal of 
the pacemaker lead (Fig. 1E and F). Pocket site swab cultures and 
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three separate sets of blood cultures were collected and later re-
vealed methicillin-resistant, Staphylococcus aureus. The patient was 
treated with vancomycin 1000 mg every 12 hours. On the tenth day, 
blood cultures were negative for the first time. The patient’s fever re-
lapsed at day 14 and three of three blood cultures grew Candida trop-
icalis (C. tropicalis).  Repeated blood cultures were positive for C. tropi-
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Fig. 2. A: brain MRI showing multiple acute infarcts in the bilateral cerebral hemispheres, suggestive of embolism. B: a CT scan of the chest showing small 
and solid cavitary nodules, suggesting septic embolism. C: a CT scan of the abdomen showing small, ill-defined, low-attenuated lesions in segment 6 of the 
liver, which can be inflammatory lesions but is difficult to characterize with single-phase CT. CT: computed tomography, MRI: magnetic resonance imaging. 
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Fig. 1. TTE demonstrating a 2.4×1.1 cm vegetation attached to the TV posterior leaflet (arrow) and a 0.8×0.8 cm vegetation attached to the RA-free wall 
(broken arrow) (A). A 0.7×0.5 cm vegetation attached to the MV anterior mitral leaflet (B). Disappearance of vegetations on both TV posterior leaflet and 
RA-free wall (C). Disappearance of MV anterior leaflet vegetation (D). Chest radiograph before device removal (E) and after device removal (F). TTE: trans-
thoracic echocardiography, LA: left atrium, LV: left ventricle, RA: right atrium, TV: tricuspid valve, MV: mitral valve.
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calis until day 18. Antifungal treatment was started intravenously 
and continued for a total of six weeks, including four weeks with li-
posomal amphotericin B 350 mg/day (5 mg/kg) and two weeks 
with fluconazole 400 mg/day. After 22 days, vegetations of tricuspid 
valve and right atrium were no longer visible on TTE (Fig. 1C and D). 
The patient was discharged after eight weeks of admission and no 
relapse was documented at the six months clinical visit.
Case 2
A 19-year-old woman was admitted for chills of three days. She 
had a history of pacemaker (VDD type) implantation five years pri-
or for high-degree atrioventricular block with recurrent syncope. 
Upon admission she was afebrile and did not reveal pacemaker 
skin redness or tenderness. Her WBC count was 12.75×103/μL and 
CRP concentration was 26.4 mg/L. TTE revealed a large vegetation 
(2.5×1.7 cm) attached to the tricuspid valve (Fig. 3A). We began 
treatment with intravenous vancomycin 1000 mg every 12 hours. 
On the third day, three different sets of blood cultures grew St-
aphylococcus epidermidis and blood cultures were positive until 
day 12. At day 15, the size of the largest vegetation increased to 3.2× 
0.8 cm. We then completely removed the previous pacemaker and 
leads (Fig. 3B) transvenously with a temporary pacemaker. Blood 
cultures were negative for the first time at day 17, but TTE revealed 
no interval change in vegetation size until day 32. Despite the lack 
of interval vegetation size change, a new pacemaker (VDD type) was 
implanted at day 32 (Fig. 3C). After successful re-implantation, treat-
ment with intravenous vancomycin was continued for a total of six 
weeks and TTE showed complete resolution of the vegetation. At 
the five-year follow-up, the TTE showed no relapse (Fig. 3D).
Discussion
Pacemaker lead endocarditis is considered to be the most severe 
form of endocarditis.5) In addition to proper antimicrobial therapy, 
complete removal of the device is required and antimicrobial ther-
apy alone is often unsuccessful and associated with a high mortality 
Fig. 3. A: TTE on admission demonstrating a 2.5×1.7 cm TV anterior leaflet vegetation (broken arrow) and a shaggy shaped 1.7×0.8 cm mass attached to 
the right atrium lateral wall (arrow), concerning for vegetation. Chest radiograph, before infected pacemaker removal (B) and after new pacemaker implan-
tation (C). Follow-up TTE five years later showing disappearance of vegetations (D). TTE: transthoracic echocardiography, LA: left atrium, LV: left ventricle, 
RA: right atrium, TV: tricuspid valve.
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rate.6) A variety of percutaneous lead-removal techniques are avail-
able, and only a small minority of patients require open cardiovas-
cular surgery for complete device removal.7) Although there has been 
no study comparing transvenous and surgical removal of leads in 
large vegetation pacemaker endocarditis, removal via open thora-
cotomy has been advocated for leads with large vegetations due 
to the possibility of dislodging emboli. Previous literature has ana-
lyzed the perceived risk of embolic events in the presence of large 
vegetations (>1.0 cm), a relative contraindication to transvenous re-
moval.7)8) Surgical removal of the device has been suggested in these 
circumstances to avoid complications such as pulmonary embo-
lism.7) Ruttmann et al.4) on the other hand, reported that the trans-
venous extraction of endocardial leads with large vegetations (>1.0 
cm) is feasible. They described that although pulmonary embolism 
does occur, it does not influence the survival or length of hospitaliz-
ation. Consistent with this report, in our two cases with large veg-
etations (maximum diameter of 3.2 cm), percutaneous lead extrac-
tion was performed successfully without complications such as 
tears of the tricuspid valve, hemothorax, tamponade, pulmonary 
embolism, or lead migration. Our cases also show that percutane-
ous removal of the infected leads is effective even in patients with 
multi-organ septic emboli. 
Our first patient no longer exhibited the signs and symptoms of 
sick sinus syndrome after complete removal of the device, so we 
did not implant a new pacemaker. The second patient needed a new 
pacemaker; however, the vegetations were persistently observed 
even two weeks after complete removal of the leads. As there were 
no signs of infection, we re-implanted the new device.
 Our report suggests that, although pacemaker lead endocarditis 
may be accompanied by large vegetations and lung and brain em-
boli, it can be treated successfully with transvenous lead extraction 
and proper antibiotics.
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